• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Poultry Vaccines Market

    ID: MRFR/Pharma/48775-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Poultry Vaccines Market Research Report By Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines), By Species (Broilers, Layers, Turkeys, Others), By Administration Route (Intramuscular, Subcutaneous, Oral, Inhalation) and By Disease Targeted (Newcastle Disease, Infectious Bursal Disease, Avian Influenza, Marek's Disease)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Poultry Vaccines Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    UK Poultry Vaccines Market Summary

    The United Kingdom UK Poultry Vaccines market is projected to experience substantial growth over the next decade.

    Key Market Trends & Highlights

    UK Poultry Vaccines Key Trends and Highlights

    • The market valuation is expected to rise from 168.8 USD Million in 2024 to 406.2 USD Million by 2035.
    • A compound annual growth rate (CAGR) of 8.31 percent is anticipated from 2025 to 2035.
    • The increasing demand for poultry products is likely to drive the need for effective vaccination solutions.
    • Growing adoption of advanced vaccination technologies due to heightened awareness of poultry health is a major market driver.

    Market Size & Forecast

    2024 Market Size 168.8 (USD Million)
    2035 Market Size 406.2 (USD Million)
    CAGR (2025-2035) 8.31%

    Major Players

    Hipra, MediVet, Ceva Santé Animale, Valogen, Zoetis, Vetoquinol, Elanco Animal Health, Hester Biosciences, Petersime, IDT Biologika, Merck Animal Health, MSD Animal Health, Poultry Health Services, Boehringer Ingelheim

    UK Poultry Vaccines Market Trends

    The UK Poultry Vaccines Market is currently experiencing notable trends driven by the increasing emphasis on biosecurity and disease prevention among poultry farmers. There is a growing awareness of the importance of vaccination to combat avian diseases, such as Newcastle disease and infectious bursal disease. This heightened focus is driven by the need to maintain the health of flocks and meet stringent food safety standards set by UK regulatory bodies. The demand for more effective vaccines is also on the rise as producers aim to enhance productivity and minimize losses associated with disease outbreaks. 

    Opportunities exist for the development of innovative vaccines that can offer broader protection and are easier to administer.With advancements in biotechnology, the potential for new vaccine formulations that combine multiple antigens could be explored to streamline vaccination processes for poultry farmers. Additionally, as the UK continues to emphasize sustainability in agriculture, there is a significant opportunity for vaccines that promote animal welfare and reduce the dependency on antibiotics, aligning with governmental initiatives for responsible farming practices. Recent trends show a shift towards personalized vaccination programs tailored to specific farm conditions and challenges faced by poultry producers. 

    This individual approach allows for more precise management of flock health, enhancing both vaccine efficacy and overall farm productivity.Moreover, the integration of digital technologies and data analytics in livestock management is beginning to influence vaccination strategies, providing farmers with tools to track the health status of their poultry and determine the optimal timing for vaccination. The evolving landscape in the UK Poultry Vaccines Market reflects a commitment to improving animal health, farm efficiency, and overall food security.

    UK Poultry Vaccines Market Drivers

    Market Segment Insights

    UK Poultry Vaccines Market Segment Insights

    UK Poultry Vaccines Market Segment Insights

    Poultry Vaccines Market Type Insights

    Poultry Vaccines Market Type Insights

    The UK Poultry Vaccines Market demonstrates a diverse range of Type segments, which play a crucial role in the overall health and productivity of poultry. Live Attenuated Vaccines hold a significant position, providing long-lasting immunity against various poultry diseases and are widely recognized for their effectiveness in preventing outbreaks. These vaccines utilize live pathogens that have been weakened, allowing birds to develop an immune response without exhibiting severe symptoms.

    Inactivated Vaccines also play a vital role, relying on killed pathogens to stimulate immunity. They are particularly favored in scenarios where safety is a primary concern, as they eliminate the risk associated with live vaccines. The UK government emphasizes the importance of biosecurity and disease prevention, which drives the demand for Inactivated Vaccines in poultry farms across the nation. Subunit Vaccines, which consist of purified proteins from pathogens, are garnering attention due to their specific targeting capabilities, offering enhanced safety profiles and reduced side effects.

    These vaccines are essential for managing complex disease challenges faced in the poultry industry, as they help in formulating targeted vaccination programs.

    Moreover, with advancements in genetic engineering, DNA Vaccines are emerging as a promising and innovative solution in the market. Offering rapid responses and high durability, they allow for the introduction of genetic material to elicit immune responses without the use of live or inactivated pathogens. This technology aligns with the increasing trend towards precision and personalized strategies in veterinary medicine. The UK Poultry Vaccines Market segmentation showcases the importance of these Types of vaccines in ensuring poultry health, enhancing productivity, and supporting sustainable farming practices while addressing regulatory standards set by veterinary organizations.

    Poultry Vaccines Market Species Insights

    Poultry Vaccines Market Species Insights

    The UK Poultry Vaccines Market, particularly in the Species segment, is characterized by a diverse array of vaccination needs tailored to various poultry breeds. Broilers play a significant role in this segment, primarily due to the high demand for chicken meat in the UK, which drives the necessity for effective vaccines to ensure health and growth. Layers are another critical segment, as they are essential for the egg production industry, necessitating vaccines that prevent diseases and enhance productivity. 

    Turkeys represent a growing area within the poultry vaccines market, with increasing consumption and production rates catering to seasonal demands, which drives the need for targeted vaccination strategies.The Others category encompasses various poultry types, such as ducks and geese, which although smaller, still contribute to the overall health management practices within the industry. The rising awareness of poultry health, biosecurity regulations, and the increasing incidence of poultry diseases are fueling growth opportunities across these species. 

    As a result, the UK Poultry Vaccines Market segmentation reflects the importance of tailored vaccination solutions to address the unique challenges faced by each poultry type, underscoring the industry's dynamic landscape.

    Poultry Vaccines Market Administration Route Insights

    Poultry Vaccines Market Administration Route Insights

    The Administration Route in the UK Poultry Vaccines Market plays a crucial role in ensuring the effective delivery of vaccines to poultry populations, thus contributing to disease management and productivity in the industry. Various administration methods, including Intramuscular, Subcutaneous, Oral, and Inhalation, cater to different needs and vaccine types. Intramuscular and Subcutaneous routes are often favored for their effectiveness in eliciting strong immune responses, making them significant in controlling avian diseases. 

    On the other hand, Oral administration offers convenience, making it suitable for mass vaccination, while Inhalation methods can help in targeting respiratory diseases that affect poultry.The choice of administration route can impact the overall efficacy of the vaccines, thereby influencing the overall health and performance of poultry farms. Given the rising need for efficient disease control in the UK poultry industry, the different routes of administration present a variety of opportunities for innovation and improvement in vaccine delivery systems, aligning with the growing focus on animal health and welfare. 

    Continued advancements in vaccine technologies and administration methods are expected to enhance the way poultry vaccines are utilized, ultimately leading to better outcomes for producers and the industry as a whole.

    Poultry Vaccines Market Disease Targeted Insights

    Poultry Vaccines Market Disease Targeted Insights

    The Disease Targeted segment of the UK Poultry Vaccines Market is crucial in safeguarding poultry health and ensuring biosecurity within the UK. This segment encompasses various diseases, including Newcastle Disease, Infectious Bursal Disease, Avian Influenza, and Marek's Disease, each playing a significant role in poultry production and public health. Newcastle Disease is often a major concern due to its highly contagious nature and potential economic impact on the poultry industry, prompting robust vaccination programs. 

    Infectious Bursal Disease, known for affecting young chickens, highlights the importance of early vaccination, emphasizing strategic planning for poultry farmers.Avian Influenza continues to pose threats globally and regionally, necessitating ongoing monitoring and vaccination efforts to prevent outbreaks and ensure food security. Marek's Disease, while not as acute, contributes to long-term production losses, underlining the need for effective vaccination strategies to maintain flock health. 

    The evolution of these diseases and the need for innovative vaccine solutions fuel market demand and drive Research and Development efforts, contributing to the overall growth and resilience of the UK Poultry Vaccines Market.

    Get more detailed insights about UK Poultry Vaccines Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The UK Poultry Vaccines Market is characterized by dynamic competitive interactions among various players, driven by the essential need for poultry health and productivity. This market landscape is shaped by the collaborative efforts of industry stakeholders who are focused on innovating vaccine development, enhancing disease control measures, and responding to the evolving needs of poultry producers. As the demand for high-quality protein sources increases, so does the emphasis on ensuring the health of poultry populations through effective vaccination strategies. 

    The competitive environment is further defined by regulatory frameworks and evolving market trends that require companies to remain adaptive and forward-thinking, leading to a continuous flow of innovations aimed at improving poultry health and production efficiency.Hipra holds a significant position in the UK Poultry Vaccines Market, being well-regarded for its innovative approach to vaccine development and its commitment to the poultry industry. The company successfully establishes its presence by focusing on specialized vaccines that cover a range of avian diseases.

    Hipra’s strengths lie in its extensive research and development capabilities, which allow it to stay ahead of industry trends and address emerging health challenges faced by poultry producers. 

    Through partnerships and collaborations with local poultry businesses and research institutions, Hipra effectively engages with stakeholders, ensuring its products are tailored to the specific needs of the UK market. The company's strong dedication to quality and efficacy in its vaccine offerings further enhances its reputation and solidifies its competitive edge.MediVet is another key player in the UK Poultry Vaccines Market, known for its robust portfolio that comprises a range of vaccines aimed at protecting poultry from various diseases. MediVet has effectively established its market presence through strategic marketing initiatives and collaborations with producers, veterinarians, and agricultural organizations. 

    The company’s strengths include its commitment to research and development, which has led to the introduction of cutting-edge vaccination solutions that enhance poultry health. In recent years, MediVet has also engaged in mergers and acquisitions to bolster its position in the UK market, allowing for the expansion of its product line and operational capabilities. This proactive approach has enabled MediVet to maintain a competitive advantage as it continues to innovate and adapt to the needs of poultry producers across the UK.

    Key Companies in the UK Poultry Vaccines Market market include

    Industry Developments

    The UK Poultry Vaccines Market has seen significant developments recently, particularly regarding vaccine advancement and distribution amid ongoing biosecurity concerns. Companies like Zoetis, Elanco Animal Health, and MSD Animal Health are focusing on innovative vaccine solutions to address the rising incidence of avian health issues. The growth in market valuation is attributed to increased investments in Research and Development, leading to enhanced vaccine efficacy, which is crucial for maintaining poultry health and productivity.

    Recent notable acquisitions include Boehringer Ingelheim's acquisition of a specific vaccine portfolio from competitors in October 2023, strengthening their position in the market. In addition, in the past year, Vetoquinol launched a new vaccine targeting respiratory diseases affecting poultry, further illustrating the sector's dynamic nature. There are indications that market growth is also driven by regulatory changes and increasing demand for biosecure poultry farming practices, as outlined by the UK government in efforts to boost food safety standards. 

    The UK Poultry Vaccines Market continues to evolve, with collaborative programs among various companies aimed at improving vaccine accessibility for poultry farmers across the nation.

    Market Segmentation

    Outlook

    • Newcastle Disease
    • Infectious Bursal Disease
    • Avian Influenza
    • Marek's Disease

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 168.75(USD Million)
    MARKET SIZE 2024 176.25(USD Million)
    MARKET SIZE 2035 406.25(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.887% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Hipra, MediVet, Ceva Santé Animale, Valogen, Zoetis, Vetoquinol, Elanco Animal Health, Hester Biosciences, Petersime, IDT Biologika, Merck Animal Health, MSD Animal Health, Poultry Health Services, Boehringer Ingelheim
    SEGMENTS COVERED Type, Species, Administration Route, Disease Targeted
    KEY MARKET OPPORTUNITIES Increased demand for disease control, Rising poultry production levels, Innovations in vaccine technology, Expansion of organic poultry sector, Enhanced biosecurity measures adoption
    KEY MARKET DYNAMICS Increasing disease outbreaks, Advancements in vaccine technology, Regulatory changes and compliance, Growing awareness of animal health, Rising demand for poultry products
    COUNTRIES COVERED UK

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the UK Poultry Vaccines Market in 2024?

    The UK Poultry Vaccines Market is expected to be valued at 176.25 million USD in the year 2024.

    What will be the projected market size of the UK Poultry Vaccines Market by 2035?

    By 2035, the overall market is expected to reach a valuation of 406.25 million USD.

    What is the expected CAGR for the UK Poultry Vaccines Market from 2025 to 2035?

    The UK Poultry Vaccines Market is anticipated to grow at a CAGR of 7.887% during the period from 2025 to 2035.

    Which type of vaccines is expected to dominate the UK Poultry Vaccines Market by 2035?

    Live Attenuated Vaccines are projected to dominate the market, with an expected valuation of 120.0 million USD by 2035.

    What are the market size projections for Inactivated Vaccines by 2035?

    Inactivated Vaccines are expected to be valued at 90.0 million USD in 2035.

    Who are the key players in the UK Poultry Vaccines Market?

    Major players include Hipra, MediVet, Ceva Santé Animale, Zoetis, and Merck Animal Health.

    What will be the market value of Subunit Vaccines in 2035?

    Subunit Vaccines are projected to reach a valuation of 60.0 million USD by 2035.

    What is the expected market value of DNA Vaccines in 2024?

    The market value for DNA Vaccines is projected to be 56.25 million USD in the year 2024.

    What is the forecast growth rate for the UK Poultry Vaccines Market during the upcoming decade?

    The market is expected to experience significant growth at a CAGR of 7.887% from 2025 to 2035.

    What opportunities for growth are present in the UK Poultry Vaccines Market?

    Emerging trends in vaccination strategies and increasing poultry health awareness present substantial growth opportunities.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. UK Poultry Vaccines Market, BY Type (USD Million)
    45. Live Attenuated Vaccines
    46. Inactivated Vaccines
    47. Subunit Vaccines
    48. DNA Vaccines
    49. UK Poultry Vaccines Market, BY Species (USD Million)
    50. Broilers
    51. Layers
    52. Turkeys
    53. Others
    54. UK Poultry Vaccines Market, BY Administration Route (USD Million)
    55. Intramuscular
    56. Subcutaneous
    57. Oral
    58. Inhalation
    59. UK Poultry Vaccines Market, BY Disease Targeted (USD Million)
    60. Newcastle Disease
    61. Infectious Bursal Disease
    62. Avian Influenza
    63. Marek's Disease
    64. Competitive Landscape
    65. Overview
    66. Competitive Analysis
    67. Market share Analysis
    68. Major Growth Strategy in the Poultry Vaccines Market
    69. Competitive Benchmarking
    70. Leading Players in Terms of Number of Developments in the Poultry Vaccines Market
    71. Key developments and growth strategies
    72. New Product Launch/Service Deployment
    73. Merger & Acquisitions
    74. Joint Ventures
    75. Major Players Financial Matrix
    76. Sales and Operating Income
    77. Major Players R&D Expenditure. 2023
    78. Company Profiles
    79. Hipra
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. MediVet
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. Ceva Santé Animale
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Valogen
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Zoetis
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. Vetoquinol
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. Elanco Animal Health
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. Hester Biosciences
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. Petersime
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. IDT Biologika
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. Merck Animal Health
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. MSD Animal Health
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. Poultry Health Services
    152. Financial Overview
    153. Products Offered
    154. Key Developments
    155. SWOT Analysis
    156. Key Strategies
    157. Boehringer Ingelheim
    158. Financial Overview
    159. Products Offered
    160. Key Developments
    161. SWOT Analysis
    162. Key Strategies
    163. References
    164. Related Reports
    165. UK Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    166. UK Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY SPECIES, 2019-2035 (USD Billions)
    167. UK Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)
    168. UK Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY DISEASE TARGETED, 2019-2035 (USD Billions)
    169. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    170. ACQUISITION/PARTNERSHIP
    171. MARKET SYNOPSIS
    172. UK POULTRY VACCINES MARKET ANALYSIS BY TYPE
    173. UK POULTRY VACCINES MARKET ANALYSIS BY SPECIES
    174. UK POULTRY VACCINES MARKET ANALYSIS BY ADMINISTRATION ROUTE
    175. UK POULTRY VACCINES MARKET ANALYSIS BY DISEASE TARGETED
    176. KEY BUYING CRITERIA OF POULTRY VACCINES MARKET
    177. RESEARCH PROCESS OF MRFR
    178. DRO ANALYSIS OF POULTRY VACCINES MARKET
    179. DRIVERS IMPACT ANALYSIS: POULTRY VACCINES MARKET
    180. RESTRAINTS IMPACT ANALYSIS: POULTRY VACCINES MARKET
    181. SUPPLY / VALUE CHAIN: POULTRY VACCINES MARKET
    182. POULTRY VACCINES MARKET, BY TYPE, 2025 (% SHARE)
    183. POULTRY VACCINES MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    184. POULTRY VACCINES MARKET, BY SPECIES, 2025 (% SHARE)
    185. POULTRY VACCINES MARKET, BY SPECIES, 2019 TO 2035 (USD Billions)
    186. POULTRY VACCINES MARKET, BY ADMINISTRATION ROUTE, 2025 (% SHARE)
    187. POULTRY VACCINES MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2035 (USD Billions)
    188. POULTRY VACCINES MARKET, BY DISEASE TARGETED, 2025 (% SHARE)
    189. POULTRY VACCINES MARKET, BY DISEASE TARGETED, 2019 TO 2035 (USD Billions)
    190. BENCHMARKING OF MAJOR COMPETITORS

    UK Poultry Vaccines Market Segmentation

     

     

     

    • Poultry Vaccines Market By Type (USD Million, 2019-2035)

      • Live Attenuated Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • DNA Vaccines

     

    • Poultry Vaccines Market By Species (USD Million, 2019-2035)

      • Broilers
      • Layers
      • Turkeys
      • Others

     

    • Poultry Vaccines Market By Administration Route (USD Million, 2019-2035)

      • Intramuscular
      • Subcutaneous
      • Oral
      • Inhalation

     

    • Poultry Vaccines Market By Disease Targeted (USD Million, 2019-2035)

      • Newcastle Disease
      • Infectious Bursal Disease
      • Avian Influenza
      • Marek's Disease

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027